Publication: The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief?
Open/View Files
Date
1995
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief? (1995 Third Year Paper)
Research Data
Abstract
Tylenol. Advil. Monistat 7. Imodium AD. These are some of the most commonly used, widely available, and successful drugs in the United States. All of them began as drugs only available by a prescription. All of them made a successful prescription-only to over-the-counter (Rx-to-OTC) switch through the switch" mechanisms of the Food and Drug Administration (FDA). Due to the amount of money that pharmaceutical companies can make with an Rx-to-OTC switch, the FDA has received dozens of switch requests in the last few years, and it expects to receive many more in the near future.
Description
Other Available Sources
Keywords
Food and Drug Law, H2 blockers, HZ blockers, Rx to OTC
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service